NCT06056310 2025-09-29Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX)EMD SeronoPhase 1 Terminated18 enrolled 9 charts
NCT03840902 2024-01-16M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)EMD SeronoPhase 2 Terminated153 enrolled 13 charts
NCT02805894 2021-05-10NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate AdenocarcinomaNanobiotixPhase 1/2 Terminated5 enrolled